IRIS - Res&Arch Institutional Research Information System - Research & Archive

COSTA, CINZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.597
EU - Europa 1.994
AS - Asia 1.034
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.592
IE - Irlanda 506
SG - Singapore 402
IT - Italia 336
UA - Ucraina 304
HK - Hong Kong 294
SE - Svezia 211
FR - Francia 189
CN - Cina 169
VN - Vietnam 108
DE - Germania 105
FI - Finlandia 97
RU - Federazione Russa 84
GB - Regno Unito 52
RO - Romania 28
KR - Corea 22
BE - Belgio 19
CZ - Repubblica Ceca 16
CH - Svizzera 12
TR - Turchia 12
NL - Olanda 10
AT - Austria 6
GR - Grecia 6
LB - Libano 6
EU - Europa 5
UZ - Uzbekistan 5
CL - Cile 3
JP - Giappone 3
LT - Lituania 3
MX - Messico 3
PH - Filippine 3
AR - Argentina 2
BR - Brasile 2
CA - Canada 2
ES - Italia 2
MO - Macao, regione amministrativa speciale della Cina 2
PL - Polonia 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
HU - Ungheria 1
IL - Israele 1
IN - India 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 5.638
Salva come PNG Salva come JPEG
Città #
Chandler 569
Dublin 501
Singapore 323
Hong Kong 292
Boardman 204
San Mateo 203
Jacksonville 170
Altamura 137
Santa Clara 132
Medford 111
Dong Ket 108
Princeton 108
Perugia 107
Lawrence 101
Wilmington 86
Ann Arbor 82
Andover 74
Beijing 71
Des Moines 51
Redmond 43
Helsinki 27
Los Angeles 26
Munich 23
Seoul 22
San Paolo di Civitate 21
Saint Petersburg 19
Bucharest 18
Woodbridge 18
Brussels 17
Norwalk 17
Ashburn 12
Dallas 10
Izmir 10
Falls Church 9
Redwood City 9
Boydton 8
London 8
Moscow 8
Brno 7
Den Haag 6
Olomouc 5
Recanati 5
Rome 5
Cava de' Tirreni 4
Falkenstein 4
Houston 4
Lappeenranta 4
Pomezia 4
Terni 4
Auburn Hills 3
Espoo 3
Frankfurt am Main 3
Guangzhou 3
Milan 3
Naples 3
San Juan 3
Washington 3
Zhengzhou 3
Changsha 2
Chiajna 2
Chicago 2
Chongqing 2
Clifton 2
Göttingen 2
Hasselt 2
Istanbul 2
Jesi 2
Lanzhou 2
Munro 2
Nagold 2
Prague 2
San Diego 2
Santiago 2
Shanghai 2
Tappahannock 2
Timisoara 2
Toronto 2
Utrecht 2
Almaty 1
Altino 1
Amsterdam 1
Assisi 1
Athens 1
Bielefeld 1
Bishkek 1
Bologna 1
Cambridge 1
City Of Industry 1
Dearborn 1
Derio 1
Dubai 1
Edinburgh 1
Ferrara 1
Florence 1
Frankfurt Am Main 1
Fremont 1
Grammichele 1
Kalngale 1
Lausanne 1
Lebrija 1
Totale 3.896
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 152
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 94
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 87
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 87
Effect of psychotropic drugs on seizure threshold 85
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 84
Levetiracetam-associated hyponatremia. 83
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 82
Plasticity and repair in the post-ischemic brain 76
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 75
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 75
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 73
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 73
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 71
Hippocampal epileptogenesis in autoimmune encephalitis 71
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 69
Occipital arteriovenous malformations andmigraine. 69
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 69
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 66
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 65
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 64
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 64
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 63
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 62
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 61
Brain arteriovenous malformations and seizures: an Italian study. 61
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 59
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 58
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 58
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 58
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 58
Neural 17beta-estradiol facilitates long-term potentiation in the hippocampal CA1 region 58
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 57
Management of epilepsy in brain tumors 56
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 55
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 55
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 55
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 55
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 54
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 53
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 53
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 53
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 52
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 51
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 51
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. 50
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 50
Cortical spreading depression as a target for anti-migraine agents. 50
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 49
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 49
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 49
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 49
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 49
Amyloid-β: a potential link between epilepsy and cognitive decline 47
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 47
Migraine and epilepsy: what value today? 46
Dopaminergic and Behavioral Deficits Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 45
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 45
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 45
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 45
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis 45
Chronic cocaine prevents depotentiation at corticostriatal synapses. 44
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 44
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 43
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. 42
Levetiracetam protects against kainic acid-induced toxicity. 42
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 42
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 42
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 42
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. 41
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 41
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 41
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 41
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 41
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. 40
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 40
Cefalee e sonno 40
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 40
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 40
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. 39
null 39
Identification of amoeba in the CSF in a patient with meningoencephalitis 38
Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina. 38
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 38
Modelli sperimentali 38
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. 37
Obsessive-compulsive disorder and migraine with medication-overuse headache. 37
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 37
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. 36
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na(+)/K(+) ATPase. 36
Late-onset n-acetylglutamate synthase deficiency: Report of a paradigmatic adult case presenting with headaches and review of the literature 36
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 36
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 36
Rivaroxaban Plasma Levels and Levetiracetam: A Case Report 34
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 34
Rivaroxaban Plasma Levels and Levetiracetam RESPONSE 33
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 32
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3 32
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 31
Striatum-hippocampusbalance: from physiological behavior to interneuronal pathology. 31
Totale 5.284
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020305 0 0 0 0 0 43 53 47 56 62 7 37
2020/2021774 7 45 27 49 226 37 65 29 86 25 59 119
2021/2022901 15 168 30 42 33 13 13 262 19 54 124 128
2022/20231.839 118 378 33 151 166 195 0 67 660 8 46 17
2023/2024806 43 75 34 10 3 3 177 11 117 26 153 154
2024/2025745 26 163 96 123 222 115 0 0 0 0 0 0
Totale 5.894